Aytu Biopharma (AYTU) Acquisitions (2015 - 2021)

Aytu Biopharma (AYTU) has reported Acquisitions for 5 consecutive years, with $15.4 million the latest figure, recorded in Q1 2021.

• On a quarterly basis, Acquisitions changed N/A year-over-year to $15.4 million in Q1 2021; TTM through Jun 2021 was $72393.0, a 0.0% change from a year earlier, with the FY2021 full-year figure at $15.7 million, up 168.75% from the prior year.
• Acquisitions was $15.4 million for Q1 2021 at Aytu Biopharma, up from $5.5 million in the prior quarter.
• Over five years, Acquisitions peaked at $15.4 million in Q1 2021 and troughed at -$5.4 million in Q2 2017.
• A 3-year average of $5.2 million and a median of $5.5 million in 2020 frame the typical range for Acquisitions.